← Open Payments lookup

JENNIFER LEWIS: Open Payments

NPI 1487421384 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,939 in 134 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $2,051 · 2025 $2,939

Food & beverage: $2,939
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP25$588
GlaxoSmithKline, LLC.17$355
Novo Nordisk Inc10$248
Boehringer Ingelheim Pharmaceuticals, Inc.12$204
Neurocrine BioSciences, Inc.3$172
PFIZER INC.9$166
Abbott Laboratories7$165
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$115
Exact Sciences Corporation5$100
Otsuka America Pharmaceutical, Inc.5$98

Products named: TRELEGY ELLIPTA, BREZTRI, FARXIGA, ELIQUIS, JARDIANCE, INGREZZA, FREESTYLE LIBRE 3, AIRSUPRA.

Industry payments across CT — which companies pay providers there.